1 / 14

SPROUT in the Design of Potential Anthelmintic Agents

SPROUT in the Design of Potential Anthelmintic Agents. By Michael Briggs. Supervisors Prof. A. P. Johnson* Dr. K. Yeap** *Ph.D. Supervisor, University of Leeds. **Industrial Supervisor, Pfizer, Sandwich, Kent. Outline of Presentation. Introduction

baris
Download Presentation

SPROUT in the Design of Potential Anthelmintic Agents

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. SPROUT in the Design of PotentialAnthelmintic Agents By Michael Briggs Supervisors Prof. A. P. Johnson* Dr. K. Yeap** *Ph.D. Supervisor, University of Leeds. **Industrial Supervisor, Pfizer, Sandwich, Kent.

  2. Outline of Presentation • Introduction • Paraherquamide Family of Natural Products • Mode of Action of the Paraherquamides • Results and Discussion • SPROUT Design Work • Summary • Acknowledgements

  3. Introduction

  4. Introduction • Only three groups of broad spectrum anthemintic drugs available • Resistance has appeared and increased in frequency. • The paraherquamides have shown the ability to render immotile worms present in the intestines of infected animals. • Found to have activity against nematodes which are resistant to current anthelmintic drugs.

  5. Paraherquamide Family • Paraherquamide A was first isolated in 1981 by Yamazaki et al. from Penicillium paraherquei. • Subsequently isolated from Penicillium charlesii along with six other analogues (Paraherquamides B-G) by a group at Merck in 1990. • Structural differences occur at the C-14 position and in the structure of ring A. M. Yamazaki et al, Tetrahedron Lett. 1981, 22, 135.

  6. Biological Activity of the Paraherquamide Family Results of biological testing of the paraherquamides against the strain of nematode Caenorhabditis elegans. • Paraherquamide A is the most active of the analogues with the synthetic dihydro analogue being the least active. • Some sort of alkyl substitution at C-14 position may be required for activity, although the C-14 hydroxy group may not be required for high activity.

  7. Mode of Action of the Paraherquamides • Paraherquamide A binds to the invertebrate nicotinic acetylcholine receptor with Ki’s of 2 pM and 1.7 nM in insect and nematode binding assays. • nACh receptors are ligand-gated ion channel found in the postsynaptic membrane of muscle cells. • A nerve signal causes acetylcholine to be released at the pre-synaptic junction. Activation of the nAChR by ACh causes the ion channel to open. • The flow of Na cations though the open ion channel initiates an electrical signal that causes the muscle to contract.

  8. Mode of Action of the Paraherquamides • N. Unwin et al reported the structure of nACh receptor at 4.6 Å resolution using electron microscopy N. Unwin et al, J. Mol. Biol. 1999, 288, 765-786.

  9. Mode of Action of the Paraherquamides Overlay of Paraherquamide A with Acetylcholine Overlay of Paraherquamide A with Nicotine • Acetylcholine and nicotine are agonists of the nACh. • Share a common pharmacophore. • Paraherquamide is able to bind to the receptor, but since it is a larger molecule than acetylcholine, it is also capable of binding to other groups outside the acetylcholine binding site. • While paraherquamide is bound, acetylcholine is unable to bind and open the ion channel resulting in paralysis of the nematode.

  10. Chemical Modifications of Paraherquamide A and Marcfortine A • Number of reports regarding the structural modifications of paraherquamide A and Marcfortine A. • Testing of the analogues has supplied additional information on the structure activity relationship of the paraherquamides. • Four important interaction centres • - 14 - CH3 • - Basic nitrogen • - Oxindole portion of the molecule • - Hydrophobic region of the dioxepin ring

  11. Design of Analogues of Paraherquamide A using SPROUT • SPROUT is a de novo ligand design program • Generates molecules that fit the steric and chemical constraints of a pharmacophore or a specific protein receptor. • The SPROUT design work has been restricted to a pharmacophore comprising the oxindole ring and the basic nitrogen. • An X-Ray crystal structure of Paraherquamide A was used to provide the spatial distance between the important interaction centres.

  12. Design of Analogues of Paraherquamide A using SPROUTCont… • Starting templates were placed at the oxindole ring and the basic nitrogen so as to satisfy the criteria of that site. Nitrogen was orientated so that its lone pair is in the same position, relative to oxindole, as in paraherquamide A.

  13. Summary • >15 SPROUT designed analogues have been synthesised • Screening by industrial partner showed low micro molar activity (< 10) for 3 of the 6 compounds that have so far been tested. • Testing of further analogues should further probe the SAR

  14. Acknowledgements Prof. Peter Johnson Dr. Kuen Yeap Dr. Chris Dutton Dr. James Eshelby EPSRC Pfizer Ash Dimitris James Jenny Keith Mark Matt Peter Saj Sam

More Related